Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 02, 2015 11:48 AM ET

Biotechnology

Company Overview of Navidea Biopharmaceuticals, Inc

Executive Profile

Julius R. Krevans M.D.

AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships
90--

Background

Dr. Julius R. Krevans, M.D. served as Chancellor Emeritus of International Medical Care at University of California at San Francisco (UCSF) from 1993 to June 2002. Dr. Krevans served as Chancellor of the University of California, San Francisco from July 1982 to May 1993 and where he was the fifth chancello. He is a distinguished physician and educator and played an important role nationally in developing public policy in medical education and in health sciences, as well ...

Corporate Headquarters

5600 Blazer Parkway
Dublin, Ohio 43017

United States

Phone: 614-793-7500
Fax: 614-793-7522

Board Members Memberships

Trustee

Education

BS
NYU Elaine A. and Kenneth G. Langone Medical Center
MD
NYU Elaine A. and Kenneth G. Langone Medical Center
BS
New York University
MD
New York University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$1.3M
Ali Fattaey Ph.D.Chief Executive Officer, President and Director
Curis, Inc.
$464.2K
Kevin T. Conroy Chairman of The Board, Chief Executive Officer and President
Exact Sciences Corporation
$861.1K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Navidea Biopharmaceuticals, Inc, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.